GUANIDYL DERIVATIVE

PROBLEM TO BE SOLVED: To obtain a new guanidyl derivative, having excellent suppressing actions on the Maillard reaction and antioxidant actions in combination and further high safety and useful for treatment and/or prevention of diabetic complications, atherosclerosis, etc. SOLUTION: This guanidyl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: OUCHIDA SHUICHI, TATSUMI TADASHI, MATSUI TOSHIAKI
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator OUCHIDA SHUICHI
TATSUMI TADASHI
MATSUI TOSHIAKI
description PROBLEM TO BE SOLVED: To obtain a new guanidyl derivative, having excellent suppressing actions on the Maillard reaction and antioxidant actions in combination and further high safety and useful for treatment and/or prevention of diabetic complications, atherosclerosis, etc. SOLUTION: This guanidyl derivative of formula I Z is S, O or NR (R" is H or a 1-4C alkyl); R is H, a 1-4C alkyl or a 2-5C acyl; A is a single bond, a 1-8C alkylene, etc.; ring D group is a group of formula II [R is H, a 1-4C alkyl or a 2-5C acyl; (1) is 0 or 1-10; R is a 1-4C alkyl; (p) is 0 or 1-2], formula III [R is a 1-7C alkyl, a halogen, etc.; (m) is 0 or 1-5] or formula IV [R is a 1-7C alkyl, phenyl, etc.; (n) is 0 or 1-3, etc.]} or its acid addition salt, e.g. a compound of formula V is cited. For example, the compound of formula V is obtained by using a compound prepared from a 3,5-di-t-butyl-4- hydroxybenzaldehyde and methyl triphenylphosphoranylideneacetate as a starting raw material through several steps.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPH0959258A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPH0959258A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPH0959258A3</originalsourceid><addsrcrecordid>eNrjZBB2D3X083SJ9FFwcQ3yDHMM8Qxz5WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8V4BHgaWppZGphaOxkQoAQAy9R5W</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GUANIDYL DERIVATIVE</title><source>esp@cenet</source><creator>OUCHIDA SHUICHI ; TATSUMI TADASHI ; MATSUI TOSHIAKI</creator><creatorcontrib>OUCHIDA SHUICHI ; TATSUMI TADASHI ; MATSUI TOSHIAKI</creatorcontrib><description>PROBLEM TO BE SOLVED: To obtain a new guanidyl derivative, having excellent suppressing actions on the Maillard reaction and antioxidant actions in combination and further high safety and useful for treatment and/or prevention of diabetic complications, atherosclerosis, etc. SOLUTION: This guanidyl derivative of formula I Z is S, O or NR (R" is H or a 1-4C alkyl); R is H, a 1-4C alkyl or a 2-5C acyl; A is a single bond, a 1-8C alkylene, etc.; ring D group is a group of formula II [R is H, a 1-4C alkyl or a 2-5C acyl; (1) is 0 or 1-10; R is a 1-4C alkyl; (p) is 0 or 1-2], formula III [R is a 1-7C alkyl, a halogen, etc.; (m) is 0 or 1-5] or formula IV [R is a 1-7C alkyl, phenyl, etc.; (n) is 0 or 1-3, etc.]} or its acid addition salt, e.g. a compound of formula V is cited. For example, the compound of formula V is obtained by using a compound prepared from a 3,5-di-t-butyl-4- hydroxybenzaldehyde and methyl triphenylphosphoranylideneacetate as a starting raw material through several steps.</description><edition>6</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1997</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19970304&amp;DB=EPODOC&amp;CC=JP&amp;NR=H0959258A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19970304&amp;DB=EPODOC&amp;CC=JP&amp;NR=H0959258A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OUCHIDA SHUICHI</creatorcontrib><creatorcontrib>TATSUMI TADASHI</creatorcontrib><creatorcontrib>MATSUI TOSHIAKI</creatorcontrib><title>GUANIDYL DERIVATIVE</title><description>PROBLEM TO BE SOLVED: To obtain a new guanidyl derivative, having excellent suppressing actions on the Maillard reaction and antioxidant actions in combination and further high safety and useful for treatment and/or prevention of diabetic complications, atherosclerosis, etc. SOLUTION: This guanidyl derivative of formula I Z is S, O or NR (R" is H or a 1-4C alkyl); R is H, a 1-4C alkyl or a 2-5C acyl; A is a single bond, a 1-8C alkylene, etc.; ring D group is a group of formula II [R is H, a 1-4C alkyl or a 2-5C acyl; (1) is 0 or 1-10; R is a 1-4C alkyl; (p) is 0 or 1-2], formula III [R is a 1-7C alkyl, a halogen, etc.; (m) is 0 or 1-5] or formula IV [R is a 1-7C alkyl, phenyl, etc.; (n) is 0 or 1-3, etc.]} or its acid addition salt, e.g. a compound of formula V is cited. For example, the compound of formula V is obtained by using a compound prepared from a 3,5-di-t-butyl-4- hydroxybenzaldehyde and methyl triphenylphosphoranylideneacetate as a starting raw material through several steps.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1997</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBB2D3X083SJ9FFwcQ3yDHMM8Qxz5WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8V4BHgaWppZGphaOxkQoAQAy9R5W</recordid><startdate>19970304</startdate><enddate>19970304</enddate><creator>OUCHIDA SHUICHI</creator><creator>TATSUMI TADASHI</creator><creator>MATSUI TOSHIAKI</creator><scope>EVB</scope></search><sort><creationdate>19970304</creationdate><title>GUANIDYL DERIVATIVE</title><author>OUCHIDA SHUICHI ; TATSUMI TADASHI ; MATSUI TOSHIAKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPH0959258A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1997</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>OUCHIDA SHUICHI</creatorcontrib><creatorcontrib>TATSUMI TADASHI</creatorcontrib><creatorcontrib>MATSUI TOSHIAKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OUCHIDA SHUICHI</au><au>TATSUMI TADASHI</au><au>MATSUI TOSHIAKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GUANIDYL DERIVATIVE</title><date>1997-03-04</date><risdate>1997</risdate><abstract>PROBLEM TO BE SOLVED: To obtain a new guanidyl derivative, having excellent suppressing actions on the Maillard reaction and antioxidant actions in combination and further high safety and useful for treatment and/or prevention of diabetic complications, atherosclerosis, etc. SOLUTION: This guanidyl derivative of formula I Z is S, O or NR (R" is H or a 1-4C alkyl); R is H, a 1-4C alkyl or a 2-5C acyl; A is a single bond, a 1-8C alkylene, etc.; ring D group is a group of formula II [R is H, a 1-4C alkyl or a 2-5C acyl; (1) is 0 or 1-10; R is a 1-4C alkyl; (p) is 0 or 1-2], formula III [R is a 1-7C alkyl, a halogen, etc.; (m) is 0 or 1-5] or formula IV [R is a 1-7C alkyl, phenyl, etc.; (n) is 0 or 1-3, etc.]} or its acid addition salt, e.g. a compound of formula V is cited. For example, the compound of formula V is obtained by using a compound prepared from a 3,5-di-t-butyl-4- hydroxybenzaldehyde and methyl triphenylphosphoranylideneacetate as a starting raw material through several steps.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JPH0959258A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title GUANIDYL DERIVATIVE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A02%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OUCHIDA%20SHUICHI&rft.date=1997-03-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPH0959258A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true